Rolando Gutierrez-Esteinou - 02 Mar 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Medical Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact for Rolando Gutierrez-Esteinou
Issuer symbol
ATAI
Transactions as of
02 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 15:04:29 UTC
Previous filing
04 Mar 2022
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +206,950 $0.000000 206,950 02 Mar 2022 Common Shares 206,950 $5.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.